Rumack-Matthew nomogram

Jump to navigation Jump to search

WikiDoc Resources for Rumack-Matthew nomogram

Articles

Most recent articles on Rumack-Matthew nomogram

Most cited articles on Rumack-Matthew nomogram

Review articles on Rumack-Matthew nomogram

Articles on Rumack-Matthew nomogram in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Rumack-Matthew nomogram

Images of Rumack-Matthew nomogram

Photos of Rumack-Matthew nomogram

Podcasts & MP3s on Rumack-Matthew nomogram

Videos on Rumack-Matthew nomogram

Evidence Based Medicine

Cochrane Collaboration on Rumack-Matthew nomogram

Bandolier on Rumack-Matthew nomogram

TRIP on Rumack-Matthew nomogram

Clinical Trials

Ongoing Trials on Rumack-Matthew nomogram at Clinical Trials.gov

Trial results on Rumack-Matthew nomogram

Clinical Trials on Rumack-Matthew nomogram at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Rumack-Matthew nomogram

NICE Guidance on Rumack-Matthew nomogram

NHS PRODIGY Guidance

FDA on Rumack-Matthew nomogram

CDC on Rumack-Matthew nomogram

Books

Books on Rumack-Matthew nomogram

News

Rumack-Matthew nomogram in the news

Be alerted to news on Rumack-Matthew nomogram

News trends on Rumack-Matthew nomogram

Commentary

Blogs on Rumack-Matthew nomogram

Definitions

Definitions of Rumack-Matthew nomogram

Patient Resources / Community

Patient resources on Rumack-Matthew nomogram

Discussion groups on Rumack-Matthew nomogram

Patient Handouts on Rumack-Matthew nomogram

Directions to Hospitals Treating Rumack-Matthew nomogram

Risk calculators and risk factors for Rumack-Matthew nomogram

Healthcare Provider Resources

Symptoms of Rumack-Matthew nomogram

Causes & Risk Factors for Rumack-Matthew nomogram

Diagnostic studies for Rumack-Matthew nomogram

Treatment of Rumack-Matthew nomogram

Continuing Medical Education (CME)

CME Programs on Rumack-Matthew nomogram

International

Rumack-Matthew nomogram en Espanol

Rumack-Matthew nomogram en Francais

Business

Rumack-Matthew nomogram in the Marketplace

Patents on Rumack-Matthew nomogram

Experimental / Informatics

List of terms related to Rumack-Matthew nomogram

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Rumack-Matthews nomogram, acetaminophen nomogram

Overview

The Rumack-Matthew nomogram is an acetaminophen toxicity nomogram plotting serum concentration of acetaminophen against the time since ingestion in an attempt to prognosticate possible liver toxicity as well as allowing a clinician to decide whether to proceed with N-Acetylcysteine (NAC) treatment or not. It is a logarithmic graph starting not directly from ingestion, but from 4 hours post ingestion after absorption is considered likely to be complete.[1][2]

Historical Perspective

The original line starting at 200 microgram/mL at 4 hours was published in 1975 by Rumack BH. and Matthew H. When the NAC study was begun in 1976, the FDA required a line that was 25% below the original line now called the treatment line. The study line which is now referred to as the treatment line was created starting at 150 microgram/mL at 4 hours and is the usual line used in the United States to determine treatment of acetaminophen overdose. This was published in 1981.

Clinical Use

In hands of skilled clinicians this nomogram allows for timely management of acetaminophen overdose. Generally, a serum plasma concentration (APAP) of 140-150 microgram/mL (or milligrams/L) at 4 hours post ingestion, indicates the need for NAC treatment. This nomogram is not used alone if the patient has altered mental status or if the history is not reliable. Rather, a second level should be drawn and plotted to see if the slope of the line remains at or above the nomogram. A formal half life may also be determined. Measure at time (t=0) upon admission of the patient to the emergency room, and a blood value at time (t=4 hrs) should be obtained and half-life calculated. If the half-life is more than 4 hours, then treatment is necessary to prevent hepatotoxicity and liver failure.[1][2][3][4]

Shown below is an image depicting the Rumack-Matthew nomogram.

References

  1. 1.0 1.1 Rumack BH, Peterson RC, Koch GG, Amara IA (1981). "Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment". Arch Intern Med. 141 (3 Spec No): 380–5. PMID 7469629.
  2. 2.0 2.1 Rumack BH (2002). "Acetaminophen hepatotoxicity: the first 35 years". J Toxicol Clin Toxicol. 40 (1): 3–20. PMID 11990202.
  3. James LP, Capparelli EV, Simpson PM, Letzig L, Roberts D, Hinson JA; et al. (2008). "Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose". Clin Pharmacol Ther. 84 (6): 684–90. doi:10.1038/clpt.2008.190. PMC 2929246. PMID 18923390.
  4. Rumack BH, Matthew H (1975). "Acetaminophen poisoning and toxicity". Pediatrics. 55 (6): 871–6. PMID 1134886.